Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RPS2 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of RPS2 mRNA | decreases expression | 12958071
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RPS2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RPS2 mRNA | affects expression | 16483693
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of RPS2 mRNA] | decreases reaction|increases expression | 16964424
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPS2 mRNA | affects cotreatment|decreases expression | 16532367
|
C095105 |
bexarotene |
bexarotene results in increased expression of RPS2 mRNA | increases expression | 16648578
|
C032036 |
bromobenzene |
bromobenzene results in increased expression of RPS2 mRNA | increases expression | 12628495
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of RPS2 mRNA | affects expression | 15963342
|
C099555 |
CD 437 |
CD 437 results in decreased expression of RPS2 mRNA | decreases expression | 12958071
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RPS2 mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RPS2 mRNA | affects cotreatment|affects expression | 17602206
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPS2 mRNA | affects cotreatment|decreases expression | 16532367
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS2 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of RPS2 mRNA | decreases expression | 18035473
|
D018684 |
Glycine Agents |
Glycine Agents results in decreased expression of RPS2 mRNA | decreases expression | 15654877
|
D018684 |
Glycine Agents |
Glycine Agents results in increased expression of RPS2 mRNA | increases expression | 16532367
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPS2 mRNA | affects cotreatment|increases expression | 17183730
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPS2 mRNA | affects cotreatment|decreases expression | 16532367
|
D012402 |
Rotenone |
Rotenone results in increased expression of RPS2 mRNA | increases expression | 19013527
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RPS2 mRNA | decreases expression | 19072884
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS2 mRNA | affects cotreatment|increases expression | 17942748
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of RPS2 mRNA | affects expression | 21346803
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPS2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.42 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
13.42 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.42 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.79 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.79 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.78 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.76 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.55 | 17162532 18056438 19052882 19061943 16434500 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.55 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.07 | 11874814 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.08 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.69 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.45 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.31 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.57 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 19232924 18177632 20603192 17688650 15238991 18775368 18558336 16609825 18985861 18316065 18396377 17507914 19460635 17157402 18940202 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.00 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.91 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.70 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.70 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
1.93 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.93 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 18705752 15700767 16124888 15673190 16097048 15721981 10355542 16227642 3786805 16192424 16050911 16011737 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.60 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.60 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.60 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.60 | 20512989 16779866 17162532 20524982 16698587 3084413 17428255 17761372 16878318 10672840 18785209 16288022 18971187 17055752 18978308 16502159 19383236 11831363 18788625 18393292 16540662 19822196 18494052 19208518 20432363 19919837 18665156 19519916 19418558 19701751 20935162 20084675 18056438 16328049 16807293 16569478 20514400 18506893 20727157 20007298 20101231 19171122 10737359 17138121 16681979 17978847 16830150 20214788 19107877 19052882 18691550 21159647 16935385 18210153 19394651 3581430 19539802 17173139 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.60 | 17306315 16507464 15276417 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.18 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.34 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.22 | 10977129 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
7.22 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.61 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.61 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.61 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.65 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.89 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.89 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.76 | 17333356 16105132 15861022 16919318 11677210 17681005 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.84 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
8.84 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.43 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.43 | 16575769 8888407 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.72 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
10.72 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
astaxanthine |
7.09 | 16964424 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
7.09 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.09 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
21.47 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
21.47 | 17522070 14550746 16227642 16109766 12392966 10915739 2444490 15968718 16393943 11739529 15619225 14725611 12958197 12540782 17562736 18071297 19420014 12705907 10663392 16781746 11834606 11461765 11421492 19739265 16081117 17906064 14986274 19416960 19370779 11743745 12153990 16177239 16485898 19085960 10774834 11287661 12594235 18713872 19164858 11529661 19923254 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
21.47 | 12628495 10092053 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
21.47 | 7440962 11566570 16227642 21278145 19085960 15027814 16177239 3732212 4309450 6623471 19336974 10092053 17522070 15998439 3786805 7179309 15968718 10915739 9327722 6884620 7120509 2869522 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
21.47 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
21.47 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
21.47 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
21.47 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.95 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.65 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.91 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.24 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.04 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.00 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.77 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.86 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.46 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.15 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.91 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.97 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.63 | 15959796 19224547 16239168 16045604 17595544 61145 12631006 12795759 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
17.63 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
17.63 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
17.63 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.74 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.98 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.10 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.10 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.52 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.25 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.22 | 12621046 16120746 15340226 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
8.22 | 15817613 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.71 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.58 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.85 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.47 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.66 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.32 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
15.28 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
15.28 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
15.28 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
15.28 | 12150543 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.85 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
7.85 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.85 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.68 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.68 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.85 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.13 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.33 | 17174718 16239168 16221502 17334410 11408273 16943688 17157831 21278145 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.33 | 20032147 19638242 18522880 18665156 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.24 | 12898905 15730626 18412020 18263696 11481614 12389079 17714472 18277467 16027843 16015684 18279442 16116963 17766677 12666154 18418968 16011737 18395914 17823541 15996030 14512876 15876570 15370692 17640975 17976157 12546737 16638106 17525996 16248980 12632512 18705752 15123356 18210741 12741479 14716496 16192424 18006644 10355542 14620537 17557913 17944888 18317297 12649538 12586293 18472332 18156304 14748882 18251166 17481882 14724832 15057751 17721639 15818738 18166357 17900296 12958196 14716833 15893842 16097048 18376398 18054572 18339082 18472094 13678700 18395095 12667390 17698563 12445421 17805973 18481824 12609069 15362042 17565644 15650968 15931870 18429990 16136751 17631135 15338365 18205269 17761835 18187930 12632514 20821823 17922224 15052691 15673190 16033810 17708605 15925388 17869086 15959796 12445418 18420326 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.24 | 19014921 16611625 19784758 12969438 19460945 16610002 11587558 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.24 | 15830285 16964402 17285989 16246199 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.24 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.96 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.96 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.24 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.24 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
17.24 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
17.24 | 12112319 19642983 19690152 15885732 15175105 18978307 19254457 19833225 19073162 2862719 19812893 19850985 19638242 20434301 19426721 19294768 20452335 19996281 20101389 9163691 12771043 2422723 18648771 19551842 18977376 19256749 16942905 20501860 20405173 19255062 19427195 20583210 18754104 21167192 19499222 19090486 20137499 21071580 10737359 21047994 20492335 20118626 21278145 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.24 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.24 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
13.33 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.33 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.33 | 3124819 18253720 17174075 18544905 19519916 18079962 21159647 18164116 19539802 18775883 19004024 19126423 9362446 17942915 19009564 16267830 2563599 18093689 18282651 18308698 17854601 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.33 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.11 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
4.72 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.72 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.72 | 17077188 15276417 17306315 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 11884234 19555203 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.00 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
3.31 | 15591091 19196722 19196723 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.01 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.42 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.47 | 1916698 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.08 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.89 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.07 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.90 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.17 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
10.17 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.51 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.43 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.63 | 19196722 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.76 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.07 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.01 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.01 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.77 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.77 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.97 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.77 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
8.77 | 17852074 12819281 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
5.08 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.08 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.27 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.37 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.54 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
5.56 | 17218051 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
5.56 | 15451049 18191903 11445065 19232380 19114014 16140633 11535288 18619942 16412576 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.94 | 15795934 15927086 18197244 15574749 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.42 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.96 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.96 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.34 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.16 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.39 | 11422049 12752131 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.37 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.03 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.34 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
9.34 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.34 | 15475178 14763951 16876388 11044598 11738929 3137016 17978042 1511512 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.36 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.36 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.79 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.16 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.16 | 19490988 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.05 | 15817613 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.39 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.48 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.02 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.87 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.08 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.37 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
8.11 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.11 | 17306315 16452187 16712894 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.49 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.17 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.83 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.63 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.15 | 14692618 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |